Hyperion DeFi (NASDAQ:HYPD) Shares Down 11.5% – Should You Sell?

Shares of Hyperion DeFi, Inc. (NASDAQ:HYPD) were down 11.5% during mid-day trading on Monday . The company traded as low as $3.03 and last traded at $3.08. Approximately 326,686 shares were traded during mid-day trading, an increase of 11% from the average daily volume of 293,538 shares. The stock had previously closed at $3.48.

Analysts Set New Price Targets

HYPD has been the topic of several analyst reports. Wall Street Zen upgraded Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperion DeFi in a research report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $2.00.

Hyperion DeFi Price Performance

The company has a 50 day moving average price of $5.75 and a 200-day moving average price of $7.55. The company has a market cap of $25.16 million, a price-to-earnings ratio of -0.76 and a beta of 2.81. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11.

Hyperion DeFi (NASDAQ:HYPD) last issued its quarterly earnings results on Friday, November 14th. The company reported $0.05 earnings per share for the quarter. Hyperion DeFi had a negative return on equity of 119.59% and a negative net margin of 62,238.41%.The company had revenue of $0.36 million during the quarter. As a group, equities research analysts predict that Hyperion DeFi, Inc. will post -41.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Hyperion DeFi stock. Virtu Financial LLC acquired a new stake in Hyperion DeFi, Inc. (NASDAQ:HYPD) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 23,065 shares of the company’s stock, valued at approximately $25,000. Virtu Financial LLC owned about 0.82% of Hyperion DeFi as of its most recent filing with the SEC. 25.84% of the stock is currently owned by hedge funds and other institutional investors.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.